{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T04:33:57Z","timestamp":1773376437948,"version":"3.50.1"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T00:00:00Z","timestamp":1358899200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0053767","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T21:56:52Z","timestamp":1358978212000},"page":"e53767","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["t(8;9)(p22;p24)\/PCM1-JAK2 Activates SOCS2 and SOCS3 via STAT5"],"prefix":"10.1371","volume":"8","author":[{"given":"Stefan","family":"Ehrentraut","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela E.","family":"Scherr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilmar","family":"Quentmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Geffers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maren","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinna","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Prochorec-Sobieszek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhett P.","family":"Ketterling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan A.","family":"Knudson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew L.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marshall E.","family":"Kadin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans G.","family":"Drexler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roderick A. F.","family":"MacLeod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,1,23]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/14728222.2011.538683","article-title":"PCM1-JAK2-fusion: a potential treatment target in myelodysplastic-myeloproliferative and other hemato-lymphoid neoplasms","volume":"15","author":"S Hoeller","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.immuni.2012.03.017","article-title":"Janus kinase deregulation in leukemia and lymphoma","volume":"36","author":"E Chen","year":"2012","journal-title":"Immunity"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"25760","DOI":"10.1074\/jbc.M500822200","article-title":"The Jak1 SH2 domain does not fulfill a classical SH2 function in Jak\/STAT signaling but plays a structural role for receptor interaction and up-regulation of receptor surface expression","volume":"280","author":"S Radtke","year":"2005","journal-title":"J Biol Chem"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nature08448","article-title":"JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin","volume":"461","author":"MA Dawson","year":"2009","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"18962","DOI":"10.1073\/pnas.0509714102","article-title":"Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation","volume":"102","author":"X Lu","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/leu.2011.283","article-title":"Centrosomal targeting of tyrosine kinase activity does not enhance oncogenicity in chronic myeloproliferative disorders","volume":"26","author":"T Bochtler","year":"2012","journal-title":"Leukemia"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/sj.leu.2404104","article-title":"A t(8;9) translocation with PCM1-JAK2 fusion in a patient with T-cell lymphoma","volume":"20","author":"J Adelaide","year":"2006","journal-title":"Leukemia"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1182\/blood.V93.12.4354","article-title":"Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling","volume":"93","author":"JM Ho","year":"1999","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V95.6.2076","article-title":"Transforming properties of chimeric TEL-JAK proteins in Ba\/F3 cells","volume":"95","author":"V Lacronique","year":"2000","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1093\/emboj\/17.18.5321","article-title":"Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL\/JAK2 fusion genes","volume":"17","author":"J Schwaller","year":"1998","journal-title":"EMBO J"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1182\/blood.V99.2.709","article-title":"Lentiviral gene transfer into peripheral blood-derived CD34+ NOD\/SCID-repopulating cells","volume":"99","author":"M Scherr","year":"2002","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4161\/cc.2.3.376","article-title":"Modulation of gene expression by lentiviral-mediated delivery of small interfering RNA","volume":"2","author":"M Scherr","year":"2003","journal-title":"Cell Cycle"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/092986708783497319","article-title":"Human leukemia and lymphoma cell lines as models and resources","volume":"15","author":"RA MacLeod","year":"2008","journal-title":"Curr Med Chem"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Drexler HG (2000) The Leukemia-Lymphoma Cell Lines FactsBook. San Diego: Academic Press.","DOI":"10.1016\/B978-012221970-2\/50177-7"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM199204233261704","article-title":"Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone","volume":"326","author":"TH Davis","year":"1992","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1073\/pnas.91.13.6002","article-title":"Loss of receptors for transforming growth factor beta in human T-cell malignancies","volume":"91","author":"ME Kadin","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"18241827","DOI":"10.3109\/10428194.2012.661856","article-title":"Chronic eosinophilic leukemia with erythroblastic proliferation and the rare translocation t(8;9)(p22;p24) with PCM1-JAK2 fusion gene: a distinct clinical, pathological and genetic entity with potential treatment target?","volume":"53","author":"M Prochorec-Sobieszek","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1200\/JCO.2010.32.8021","article-title":"Safety and efficacy of TG101348, a selective JAK2 inhibitor, in myelofibrosis","volume":"29","author":"A Pardanani","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1182\/blood-2009-11-255232","article-title":"The STAT5 inhibitor pimozide decreases survival of chronic myelogenous leukemia cells resistant to kinase inhibitors","volume":"117","author":"EA Nelson","year":"2011","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nprot.2007.29","article-title":"Cytogenetic harvesting of commonly used tumor cell lines","volume":"2","author":"RA MacLeod","year":"2007","journal-title":"Nat Protoc"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Smyth GK (2005) Limma: linear models for microarray data. In: Gentleman RC, V.; Dudoit, S.; Irizarry, R.; Huber, W., editor. Bioinformatics and Computational Biology Solutions using R and Bioconductor. New York: Springer. pp. 397\u2013420.","DOI":"10.1007\/0-387-29362-0_23"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/leu.2008.226","article-title":"SOCS2: inhibitor of JAK2V617F-mediated signal transduction","volume":"22","author":"H Quentmeier","year":"2008","journal-title":"Leukemia"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1182\/blood-2011-11-395228","article-title":"JAK inhibitors for myeloproliferative neoplasms: clarifying facts from myths","volume":"119","author":"A Tefferi","year":"2012","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1182\/blood-2012-06-433821","article-title":"Ruxolitinib inhibits transforming JAK2 fusion proteins in vitro and induces complete cytogenetic remission in t(8;9)(p22;p24)\/PCM1-JAK2-positive chronic eosinophilic leukemia","volume":"120","author":"E Lierman","year":"2012","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1365-2141.2012.09108.x","article-title":"Janus kinase inhibition and its effect upon the therapeutic landscape for myelofibrosis: from palliation to cure?","volume":"157","author":"C Harrison","year":"2012","journal-title":"Br J Haematol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/sj.leu.2404081","article-title":"JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders","volume":"20","author":"H Quentmeier","year":"2006","journal-title":"Leukemia"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.278.5341.1309","article-title":"A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia","volume":"278","author":"V Lacronique","year":"1997","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood.V90.7.2535","article-title":"Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia","volume":"90","author":"P Peeters","year":"1997","journal-title":"Blood"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1097-2765(00)00067-8","article-title":"Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL\/JAK2","volume":"6","author":"J Schwaller","year":"2000","journal-title":"Mol Cell"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1210\/me.2006-0096","article-title":"In vivo transcript profiling and phylogenetic analysis identifies suppressor of cytokine signaling 2 as a direct signal transducer and activator of transcription 5b target in liver","volume":"21","author":"OM Vidal","year":"2007","journal-title":"Mol Endocrinol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1084\/jem.20101167","article-title":"SOCS2 regulates T helper type 2 differentiation and the generation of type 2 allergic responses","volume":"208","author":"CA Knosp","year":"2011","journal-title":"J Exp Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.immuni.2011.12.015","article-title":"Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity","volume":"36","author":"JJ Babon","year":"2012","journal-title":"Immunity"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.semcdb.2008.07.010","article-title":"SOCS regulation of the JAK\/STAT signalling pathway","volume":"19","author":"BA Croker","year":"2008","journal-title":"Semin Cell Dev Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cytogfr.2008.08.006","article-title":"The many faces of the SOCS box","volume":"19","author":"J Piessevaux","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1182\/blood.V97.4.1056","article-title":"STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma","volume":"97","author":"C Brender","year":"2001","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e22148","DOI":"10.1371\/journal.pone.0022148","article-title":"JAK2 V617F-dependent upregulation of PU.1 expression in the peripheral blood of myeloproliferative neoplasm patients","volume":"6","author":"T Irino","year":"2011","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1042\/bj3530109","article-title":"Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling","volume":"353","author":"D Lejeune","year":"2001","journal-title":"Biochem J"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.leu.2403610","article-title":"Constitutive SOCS-3 expression protects T-cell lymphoma against growth inhibition by IFNalpha","volume":"19","author":"C Brender","year":"2005","journal-title":"Leukemia"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1182\/blood.V99.5.1766","article-title":"Overexpression of SOCS-2 in advanced stages of chronic myeloid leukemia: possible inadequacy of a negative feedback mechanism","volume":"99","author":"B Schultheis","year":"2002","journal-title":"Blood"},{"key":"ref40","article-title":"SOCS2 is dispensable for BCR\/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function","author":"N Hansen","year":"2012","journal-title":"Leukemia"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0014-5793(99)00681-X","article-title":"Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction","volume":"453","author":"H Favre","year":"1999","journal-title":"FEBS Lett"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"9115","DOI":"10.1128\/MCB.25.20.9115-9126.2005","article-title":"SOCS2 can enhance interleukin-2 (IL-2) and IL-3 signaling by accelerating SOCS3 degradation","volume":"25","author":"GM Tannahill","year":"2005","journal-title":"Mol Cell Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1172\/JCI200522710","article-title":"SOCS2 negatively regulates growth hormone action in vitro and in vivo","volume":"115","author":"CJ Greenhalgh","year":"2005","journal-title":"J Clin Invest"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1182\/blood-2006-08-039735","article-title":"The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3","volume":"109","author":"MB Hookham","year":"2007","journal-title":"Blood"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1600-065X.2010.00954.x","article-title":"From the cradle to the grave: activities of GATA-3 throughout T-cell development and differentiation","volume":"238","author":"T Hosoya","year":"2010","journal-title":"Immunol Rev"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.4049\/jimmunol.171.7.3542","article-title":"Genetic reprogramming of primary human T cells reveals functional plasticity in Th cell differentiation","volume":"171","author":"MS Sundrud","year":"2003","journal-title":"J Immunol"},{"key":"ref47","doi-asserted-by":"crossref","DOI":"10.4161\/cbt.12.12.18144","article-title":"The role of cytokine signaling in the pathogenesis of cutaneous T-cell lymphoma","volume":"12","author":"RM Abraham","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/jid.2011.27","article-title":"Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3\/Stat3 signaling pathway","volume":"131","author":"T Krejsgaard","year":"2011","journal-title":"J Invest Dermatol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ajhg.2012.02.020","article-title":"Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci","volume":"90","author":"D Ellinghaus","year":"2012","journal-title":"Am J Hum Genet"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1038\/jid.2011.140","article-title":"Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation","volume":"131","author":"JS Fridman","year":"2011","journal-title":"J Invest Dermatol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0053767","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,5]],"date-time":"2024-05-05T04:23:01Z","timestamp":1714882981000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0053767"}},"subtitle":[],"editor":[{"given":"Jose Angel","family":"Martinez Climent","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,23]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0053767","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,23]]}}}